Report Library
All ReportsDatamonitor Hemophilia KOL Interviews
December 01, 2016
Datamonitor interviewed two hemophilia specialists, one based in Germany and the other in the US, to determine their current treatment
practices and views on pipeline and marketed drugs, clinical trial designs, and pricing and market access. The two interviews were
combined into a single report.
If you are a KOL Insight Subscriber, please access the first and second interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
If you are a KOL Insight Subscriber, please access the first and second interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: |
Hemophilia A
Hemophilia A and B - General Clotting Products Hemophilia B |